A Clinical Trial to Assess the Effectiveness of NRF2 Activator (Oral Sodium-copper- Chlophyllin ) in Locally Advanced Cervical Cancer to Reduce Late Radiotherapy Toxicity.

Clinical trial NCT07164534 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07164534
Sponsor: Tata Memorial Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Uterine Cervical Neoplasm

Start date: 2026-03-01
Primary completion: 2030-03-01
Enrollment: 316

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.